Literature DB >> 1638659

A low-cost, community-based measles outbreak investigation with follow-up action.

R M Weeks1, J F Barenzi, J R Wayira.   

Abstract

An outbreak of measles in Kampala, Uganda, in 1990 raised concern about the effectiveness of the measles vaccine that was used. The Uganda EPI programme and the medical office of the Kampala City Council therefore conducted a community-based investigation, with door-to-door interviews in two selected communities. They revealed 68 measles cases ranging in age from 5 months to 12 years; the highest age-specific attack rate (32%) was found in children aged 12 to 23 months. BCG immunization coverage was high (85%), but measles immunization coverage was moderate (48%). One community, served by a mobile clinic, presented a vaccine efficacy of only 55%. Responses by mothers revealed that many had failed to have their children completely immunized because of a lack of information, and not because of difficulties in access to the service. In a follow-up, community leaders initiated monthly checking of immunization cards of both children and mothers. The low vaccine efficacy found in one of the communities resulted in a thorough assessment of the city's cold chain. This community-based approach proved to be cost-effective and practical for identifying the obstacles to effective immunization delivery.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Age Factors; Community Surveys; Cost Benefit Analysis; Data Collection; Delivery Of Health Care; Demographic Factors; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Epidemiologic Methods; Evaluation; Health; Health Services; Immunization; Incidence; Interviews; Measles; Measurement; Organization And Administration; Population; Population Characteristics; Primary Health Care; Program Evaluation; Programs; Quantitative Evaluation; Research Methodology; Sampling Studies; Studies; Surveys; Uganda; Viral Diseases

Mesh:

Substances:

Year:  1992        PMID: 1638659      PMCID: PMC2393277     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  Measles control efforts in urban Africa complicated by high incidence of measles in the first year of life.

Authors:  W R Taylor; R K Mambu; M ma-Disu; J M Weinman
Journal:  Am J Epidemiol       Date:  1988-04       Impact factor: 4.897

Review 2.  The epidemiology of measles in a partially vaccinated population in an African city: implications for immunization programs.

Authors:  F Dabis; A Sow; R J Waldman; P Bikakouri; J Senga; G Madzou; T S Jones
Journal:  Am J Epidemiol       Date:  1988-01       Impact factor: 4.897

3.  Estimating health service utilization, immunization coverage, and childhood mortality: a new approach in Uganda.

Authors:  M D Malison; P Sekeito; P L Henderson; R V Hawkins; S I Okware; T S Jones
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

4.  Field evaluation of vaccine efficacy.

Authors:  W A Orenstein; R H Bernier; T J Dondero; A R Hinman; J S Marks; K J Bart; B Sirotkin
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

5.  The use of evaluation to improve the Expanded Programme on Immunization in Mozambique.

Authors:  F Cutts; A Soares; A V Jecque; J Cliff; S Kortbeek; S Colombo
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

  5 in total
  3 in total

1.  [A survey on vaccine efficacy in the city of Bongor (Chad) and its operational consequences for the vaccination program].

Authors:  J C Luthi; W Kessler; M Boelaert
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

Review 2.  Immunization in urban areas: issues and strategies.

Authors:  S J Atkinson; J Cheyne
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

3.  A review of data needed to parameterize a dynamic model of measles in developing countries.

Authors:  Emily K Szusz; Louis P Garrison; Chris T Bauch
Journal:  BMC Res Notes       Date:  2010-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.